Cardinal Health (NYSE:CAH) Now Covered by Barclays

Research analysts at Barclays assumed coverage on shares of Cardinal Health (NYSE:CAH) in a research note issued to investors on Monday, MarketBeat reports. The firm set an “overweight” rating on the stock.

CAH has been the topic of a number of other reports. Argus raised their price target on Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a research note on Tuesday, November 4th. Leerink Partners raised their target price on Cardinal Health from $211.00 to $230.00 and gave the stock an “outperform” rating in a research report on Monday, November 17th. Deutsche Bank Aktiengesellschaft boosted their price target on Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research note on Tuesday, November 18th. Citigroup upped their price target on shares of Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a research report on Friday, October 31st. Finally, TD Cowen raised their price objective on shares of Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $209.00.

Cardinal Health Stock Down 0.4%

CAH opened at $198.01 on Monday. The stock has a market capitalization of $47.05 billion, a price-to-earnings ratio of 29.87, a PEG ratio of 1.45 and a beta of 0.63. The firm has a 50 day moving average price of $184.29 and a 200-day moving average price of $165.86. Cardinal Health has a twelve month low of $114.60 and a twelve month high of $214.93.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company had revenue of $64.01 billion for the quarter, compared to analysts’ expectations of $59.41 billion. During the same quarter last year, the company posted $1.88 earnings per share. The firm’s quarterly revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts expect that Cardinal Health will post 7.95 earnings per share for the current year.

Institutional Trading of Cardinal Health

Several institutional investors and hedge funds have recently modified their holdings of CAH. MRP Capital Investments LLC lifted its stake in shares of Cardinal Health by 95.0% during the 3rd quarter. MRP Capital Investments LLC now owns 4,925 shares of the company’s stock valued at $827,000 after buying an additional 2,400 shares in the last quarter. Saranac Partners Ltd bought a new stake in Cardinal Health during the third quarter valued at about $94,000. Severin Investments LLC lifted its position in shares of Cardinal Health by 9.0% in the third quarter. Severin Investments LLC now owns 5,006 shares of the company’s stock valued at $786,000 after acquiring an additional 414 shares in the last quarter. IFP Advisors Inc lifted its position in shares of Cardinal Health by 123.2% in the third quarter. IFP Advisors Inc now owns 4,286 shares of the company’s stock valued at $681,000 after acquiring an additional 2,366 shares in the last quarter. Finally, Swiss Life Asset Management Ltd boosted its stake in shares of Cardinal Health by 73.3% in the third quarter. Swiss Life Asset Management Ltd now owns 76,736 shares of the company’s stock worth $12,044,000 after acquiring an additional 32,464 shares during the period. 87.17% of the stock is currently owned by institutional investors.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.